Lieke Lamont
Facility Manager
- Naam
- Dr. L. Lamont
- Telefoon
- 071 5272727
- l.lamont@lacdr.leidenuniv.nl
- ORCID iD
- 0000-0002-2779-124X
Facility Manager
- LACDR
- Metabolomics and Analytics Centre
- Zhang L., Szili-Torok T., Lamont L., Kindt A.S.D., Harms A.C., Bakker J.L., Gansevoort R., Borst H.M. de & Hankemeier T. (2026), Pre- and post-diagnosis signalling lipid profiles in heart failure with preserved ejection fraction: a prospective cohort study, EBioMedicine 126: 106235.
- Goris M.M., Valdez M.E., Lamont L., Yang W., Harms A.C., Karu N., Bos S., Geerlings J.J.B., Ottenhoff T., Tsonaka R., Roukens A.H.E., Arbous M.S., Joosten S.A., Hankemeier T. & Kindt A. (2026), Tracking COVID-19 severity and progression through amines and lipid mediators, Journal of Medical Virology 98(7): e71030.
- Thangavelu M.U., Kindt A.S.D., Wouters B., Lamont L., Elfrink H.L., Harms A.C. & Hankemeier T. (2026), Volumetric absorptive microsampling for profiling of signaling lipids: a comparative analysis with whole blood and dried blood spots, Analytical and Bioanalytical Chemistry 418(9): 2565-2578.
- Zhu M., Lamont L., Maas P., Harms A.C., Beekman M., Slagboom P.E., Dubbelman A.C. & Hankemeier T. (2025), Matrix effect evaluation using multi-component post-column infusion in untargeted hydrophilic interaction liquid chromatography-mass spectrometry plasma metabolomics, Journal of Chromatography A 1740: 465580.
- Zhang L., Wernet J.M., Rothgangel A., Braun S., Ummels D., Beekman E., Jong-van Luxzenburg T. de, Kruif M.D. de, Yang W., Lamont L., Kindt A.S.D., Hankemeier T., Harms A.C. & Wietmarschen H. van (2025), Characterizing COPD phenotypes with a targeted signaling lipids metabolomics approach, Life Sciences 364: 123438.
- Zhu M., Lamont L., Maas P., Harms A.C., Beekman M., Slagboom P.E., Dubbelman A.C. & Hankemeier T. (2025), Absolute quantification of polar metabolites using matrix-free calibration curves and post-column infusion of standards in HILIC-MS based metabolomics, Journal of Chromatography A 1764: 466507.
- Thangavelu M.U., Ronde E., Lamont L., Elfrink H.L., Harms A.C., Rijke Y.B. de, Franx A., Meij T.G.J. de, Kindt A.S.D., Reiss I.K.M., Schoenmakers S. & Hankemeier T. (2025), Maternal urinary metabolomic signatures preceding spontaneous preterm birth: a pilot study, Scientific Reports 15(1): 45771.
- Peet M.P. van der, Maas P., Wegrzyn A., Lamont L., Fleming R., Bordes C., Debette S., Harms A.C., Hankemeier T. & Kindt A.S.D. (2025), mzQuality: an open-source software tool for quality monitoring and reporting of targeted mass spectrometry measurements, Journal of The American Society for Mass Spectrometry 36(8): 1669-1676.
- Zhang Z., Karu N., Kindt A.S.D., Singh M., Lamont L., Gammeren A.J. van, Ermens A.A.M., Harms A.C., Lutzen P., Vermeulen R.C.H, Dik W.A., Langerak A.W. , Velden V.H.J. van der & Hankemeier T. (2024), Association of altered plasma lipidome with disease severity in COVID-19 patients, Biomolecules 14(3): 296.
- Vanmaele A., Bouwens E., Hoeks S.E., Kindt A.S.D., Lamont L., Fioole B., Budde R.P.J., Raa S. ten, Hussain B., Oliveira-Pinto J., Ijpma A.S., Lier F. van, Akkerhuis K.M.,Majoor-Krakauer D.F., Bruin J. L. de, Hankemeier T., Rijke Y. de, Verhagen H.J.M., Boersma E. & Kardys I. (2024), Targeted plasma multi-omics propose glutathione, glycine and serine as biomarkers for abdominal aortic aneurysm growth on serial CT scanning, Atherosclerosis 398: 118620.
- Yang W., Schoeman J.C., Di X., Lamont L., Harms A.C. & Hankemeier T. (2024), A comprehensive UHPLC-MS/MS method for metabolomics profiling of signaling lipids: markers of oxidative stress, immunity and inflammation, Analytica Chimica Acta 1297: 342348.
- Vanmaele A., Bouwens E., Hoeks S.E., Kindt A.S.D., Lamont L., Fioole B., Moelker A., Raa S. ten, Hussain B., Oliveira -Pinto J., Ijpma A.S., Lier F. van, Akkerhuis K.M., Majoor-Krakauer D.F., Hankemeier T., Rijke Y. de, Verhagen H.J.M., Boersma E. & Kardys I. (2024), Targeted proteomics and metabolomics for biomarker discovery in abdominal aortic aneurysm and post-EVAR sac volume, Clinica Chimica Acta 554: 117786.
- Karu N., Kindt A., Lamont L., Gammeren A.J. van, Ermens A.A.M., Harms A.C., Portengen L., Vermeulen R.C.H. Dik W.A., Langerak A.W., Velden V.H.J. van der & Hankemeier T. (2022), Plasma oxylipins and their precursors are strongly associated with COVID-19 severity and with immune response markers, Metabolites 12(7): 619.